INOVA is excited to announce that we have received FDA 510(k) clearance and CE marking for another assay in our multiplex product line.

The QUANTA Plex™ Celiac IgA assay offers IgA autoantibody determinations for human tTG and deamidated gliadin peptide (DGP) as well as providing IgA deficiency status, all in a single well! The presence of these antibodies in conjunctioin with other laboratory and clinical findings is an aid in the diagnosis of the gluten sensitive enteropathy, celiac disease. Insufficient IgA indicates that there is not enough IgA to allow detection of IgA anti-h-tTG or anti-DGP.

For more information click on the products link and go to either Technology Type, "QUANTA Plex™" or Disease State, "Gastrointestinal", then click on item #708940.